Please assess the completion status of the following clinical trial:

Trial Title: An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel Syndrome

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* 18-65 years of age~* Subjects must have been diagnosed with irritable bowel syndrome by a physician~* Subjects must have had gastrointestinal symptoms for 2 or more days per week for \> 6 months~Exclusion Criteria:~* Lifetime history of bipolar disorder, psychotic disorder, or obsessive-compulsive disorder~* Current (within past 6 months) diagnosis of major depressive disorder or substance abuse disorder~* Active suicidal/homicidal ideation~* Pregnant women or women of child-bearing potential not using an approved methods of contraception~* Individuals with an unstable medical condition that in the opinion of the investigator would interfere with the interpretation of symptoms

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: OTHER): 12-week, open-label trial of duloxetine in subjects with IBS.

Based on this trial design, predict the completion outcome and termination type (if applicable).